Real-time polymerase chain reaction assay for the rapid detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers

Clinical Infectious Diseases

Volumn 42, Issue 5, 2006, Pages 622-627

  Farcas, Gabriella A ^a,b   Soeller, Rainer ^c   Zhong, Kathleen ^a   Zahirieh, Alireza ^a   Kain, Kevin C ^a,b,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Artus GmbH   (Germany)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE;

ARTICLE; CLINICAL LABORATORY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; GEOGRAPHIC DISTRIBUTION; HAPLOTYPE; HUMAN; HUMAN CELL; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; TRAVEL;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; HUMANS; INDIA; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PROTOZOAN PROTEINS; SENSITIVITY AND SPECIFICITY; TRAVEL;

EID: 33144471114     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/500134     Document Type: Article

References (41)

1. Newman RD, Parise ME, Barber AM, Steketee RW. Malaria-related deaths among U.S. travelers, 1963-2001. Ann Intern Med 2004; 141: 547-55.
2. Kain KC, MacPherson DW, Kelton T, et al. Malaria deaths in visitors to Canada and in Canadian travelers: a case series. CMAJ 2001; 164: 654-9.
3. Amexo M, Tolhurst R, Barnish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet 2004; 364:1896-8.
4. Ohrt C, Purnomo MA, Sutamihardja D, Tang, Kain KC. Impact of microscopy error on estimates of protective efficacy in malaria-prevention trials. J Infect Dis 2002; 186:540-6.
5. McKenzie FE, Sirichaisinthop J, Miller RS, Gasser RA, Wongsrichanalai C. Dependence of malaria detection and species diagnosis by microscopy on parasite density. Am J Trop Med Hyg 2003; 69:372-6.
6. Causer LM, Filler S, Wilson M, Papagiotas S, Newman RD. Evaluation of reported malaria chemoprophylactic failure among travelers in a US University Exchange Program, 2002. Clin Infect Dis 2004; 39:1583-8.
7. Brown AE, Kain KC, Pipithkul J, Webster HK. Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infections undetected by conventional microscopy. Trans R Soc Trop Med Hyg 1992; 86:609-12.
8. Labbe AC, Patel SN, Crandall IE, Kain KC. Travelers as a molecular surveillance system for drug-resistant malaria. Emerg Infect Dis 2003;9: 33-6.
9. Wichmann O, Muehlberger N, Jelinek T, et al. Screening for mutations related to atovaquone/proguanil resistance in treatment failures and other imported isolates of Plasmodium falciparum in Europe. J Infect Dis 2004; 190:1541-6.
10. Wellems TE. Plasmodium chloroquine resistance and the search for a replacement antimalarial drug. Science 2002; 298:124-6.
11. Wellems TE. Transporter of a malaria catastrophe. Nature Medicine 2004; 10:1169-71.
12. Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis 2001; 184:770-6.
13. Mita T, Kaneko A, Lum JK, et al. Recovery of chloroquine sensitivity and low prevalence of the Plasmodium falciparum chloroquine resistance transporter gene mutation K76T following the discontinuance of chloroquine use in Malawi. Am J Trop Med Hyg 2003; 68:413-5.
14. Kublin JG, Cortese JF, Njunju EM, et al. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. J Infect Dis 2003; 187:1870-5.
15. Borrmann S, Binder RK, Adegnika AA, et al. Reassessment of the resistance of Plasmodium falciparum to chloroquine in Gabon: implications for the validity of tests in vitro vs. in vivo. Trans R Soc Trop Med Hyg 2002; 96:660-3.
16. Liu DQ, Liu RJ, Ren DX, et al. Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China. Bull World Health Organ 1995; 73:483-6.
17. Le Bras J, Pradines B, di Piazza JP, et al. Resistance to chloroquine and cycloguanil of Plasmodium falciparum in patients arriving in France after travel in Africa without chemoprophylaxis. Bull Soc Pathol Exot 1998; 91:490-2.
18. Ralaimazava P, Durand R, Godineau N, et al. Profile and evolution of the chemosusceptibility of falciparum malaria imported into France in 2000. Euro Surveill 2002; 7:113-8.
19. Cooper RA, Ferdig MT, Su XZ, et al. Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol 2002;61:35-42.
20. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 2000; 6:861-71.
21. Johnson DJ, Fidock DA, Mungthin M, et al. Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol Cell 2004; 15:867-77.
22. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001; 344: 257-63.
23. Pieroni P, Mills CD, Ohrt C, Harrington MA, Kain KC. Comparison of the ParaSight-F test and the ICT Malaria Pf test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers. Trans R Soc Trop Med Hyg 1998;92:166-9.
24. Snounou G, Viriyakosol S, Zhu XP, et al. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Mol Biochem Parasitol 1993; 61:315-20.
25. Zhong KJ, Kain KC. Evaluation of a colorimetric PCR-based assay to diagnose Plasmodium falciparum malaria in travellers. J Clin Microbiol 1999; 37:339-41.
26. Pillai DR, Labbe AC, Vanisaveth V, et al. Plasmodium falciparum malaria in Laos: chloroquine treatment outcome and predictive value of molecular markers. J Infect Dis 2001; 183:789-95.
27. Vieira PP, Ferreira MU, Alecrim MG, et al. Pfcrt polymorphism and the spread of chloroquine resistance Plasmodium falciparum populations across the Amazon Basin. J Infect Dis 2004; 190:417-24.
28. Miller WC. Bias in discrepant analysis: when two wrongs don't make a right. J Clin Epidemiol 1998; 51:219-31.
29. Hadgu A. The discrepancy in discrepant analysis. Lancet 1996; 348: 592-3.
30. Ryan ET, Wilson ME, Kain KC. Illness after international travel. N Engl J Med 2002; 347:505-16.
31. Muhlberger N, Jelinek T, Behrens RH, et al. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in european patients: observations from TropNetEurop and SIMPID surveillance data. Clin Infect Dis 2003; 36:990-5.
32. Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis 1998; 27:142-9.
33. Molyneux M, Fox R. Diagnosis and treatment of malaria in Britain. BMJ 1993; 306:1175-80.
34. Marx A, Pewsner D, Egger M, et al. Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas. Ann Intern Med 2005; 142:836-46.
35. de Monbrison F, Raynaud D, Latour-Fondanaiche C, et al. Real-time PCR for chloroquine sensitivity assay and for pfmdr1-pfcrt single nucleotide polymorphisms in Plasmodium falciparum. J Microbiol Methods 2003; 54:391-401.
36. Vessiere A, Berry A, Fabre R, Benoit-Vical F, Magnaval JF. Detection by real-time PCR of the Pfcrt T76 mutation, a molecular marker of chloroquine-resistant Plasmodium falciparum strains. Parasitol Res 2004; 93:5-7.
37. Farcas GA, Zhong K, Mazzulli T, Kain KC. Development and evaluation of real-time PCR for the detection of malaria in returned travelers. J Clin Microbiol 2004; 42:636-8.
38. Fivelman QL, Butcher GA, Adagu IS, Warhurst DC, Pasvol G. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar J 2002; 1:1.
39. Schwartz E, Bujanover S, Kain KC. Genetic confirmation of atovaquone-proguanil-resistant Plasmodium falciparum malaria acquired by a nonimmune traveler to East Africa. Clin Infect Dis 2003; 37:450-1.
40. Kuhn S, Gill MJ, Kain KC. Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveler to west Africa. Am J Trop Med Hyg 2005; 72:407-9.
41. White NJ, Nosten F, Looareesuwan S, et al. Averting a malaria disaster. Lancet 1999;353:1965-7.